TY - JOUR
AU1 - Singh, Sonal
AU2 - Li, Xiaojuan
AU3 - Cocoros, Noelle M.
AU4 - Antonelli, Mary T.
AU5 - Avula, Ramya
AU6 - Crawford, Sybil L.
AU7 - Dashevsky, Inna
AU8 - Fouayzi, Hassan
AU9 - Harkins, Thomas P.
AU1 - Mazor, Kathleen M.
AU1 - Michnick, Ashley I.
AU1 - Parlett, Lauren
AU1 - Paullin, Mark
AU1 - Platt, Richard
AU1 - Rochon, Paula A.
AU1 - Saphirak, Cassandra
AU1 - Si, Mia
AU1 - Zhou, Yunping
AU1 - Gurwitz, Jerry H.
AB - 
Key PointsQuestionDoes a one-time mailed educational intervention to patients and their clinicians reduce prescribing of antipsychotics, sedative-hypnotics, and strong anticholinergic agents in community-dwelling persons living with Alzheimer disease (AD) or AD-related dementias (ADRD)?
FindingsIn this randomized clinical trial of 12 787 patients, there were no clinically meaningful or statistically significant differences from the mailed educational intervention compared with usual care in continued use of medications targeted for deprescribing.
MeaningReducing the use of potentially inappropriate, high-risk medications in the AD and ADRD population may not be achievable with mailed educational interventions directed at patients, their caregivers, and their clinicians.

TI - High-Risk Medications in Persons Living With Dementia
JF - JAMA Internal Medicine
DO - 10.1001/jamainternmed.2024.5632
DA - 2024-10-21
UR - https://www.deepdyve.com/lp/american-medical-association/high-risk-medications-in-persons-living-with-dementia-p00QJKKw50
SP - 1426
EP - 1433
VL - 184
IS - 12
DP - DeepDyve
ER -